| scholarly article | Q13442814 |
| P2093 | author name string | Jesus Pintor | |
| Basilio Colligris | |||
| Hanan Awad Alkozi | |||
| P2860 | cites work | Evolutionary divergence and functions of the human interleukin (IL) gene family | Q21245454 |
| ZAP70: a master regulator of adaptive immunity | Q24298531 | ||
| Essential role for ZAP-70 in both positive and negative selection of thymocytes | Q24321424 | ||
| Lacritin and the tear proteome as natural replacement therapy for dry eye | Q24594010 | ||
| Fate mapping of IL-17-producing T cells in inflammatory responses | Q24621244 | ||
| Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity | Q24680778 | ||
| Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins | Q27860890 | ||
| Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases | Q28241769 | ||
| MMP-9 and the perioperative management of LASIK surgery | Q33887903 | ||
| Cytokine receptor signaling pathways | Q33916985 | ||
| Regional localization of the interferon-beta 2/B-cell stimulatory factor 2/hepatocyte stimulating factor gene to human chromosome 7p15-p21. | Q34172767 | ||
| A clinical study of the efficacy of topical corticosteroids on dry eye. | Q34943771 | ||
| Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? | Q34952967 | ||
| CP-690550, a JAK3 inhibitor as an immunosuppressant for the treatment of rheumatoid arthritis, transplant rejection, psoriasis and other immune-mediated disorders | Q34980351 | ||
| Jaks, STATs, Cytokines, and Sepsis | Q34987949 | ||
| Interleukin-17 in various ocular surface inflammatory diseases | Q35072565 | ||
| Influence of sex hormones and genetic predisposition in Sjögren's syndrome: a new clue to the immunopathogenesis of dry eye disease | Q35812987 | ||
| JAK Kinases in Health and Disease: An Update | Q36285745 | ||
| Burning mouth syndrome: an update on recent findings | Q36611151 | ||
| Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease | Q36776787 | ||
| Next-generation calcineurin inhibitors for ophthalmic indications | Q36964677 | ||
| Evaluation of dry eye. | Q38021053 | ||
| Targeting IL-17 and TH17 cells in chronic inflammation | Q38047820 | ||
| Silencing human genetic diseases with oligonucleotide-based therapies. | Q38089634 | ||
| Ketotifen is an antimalarial prodrug of norketotifen with blood schizonticidal and liver-stage efficacy. | Q38465613 | ||
| Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazine | Q39195285 | ||
| Effect of periocular humidity on the tear film lipid layer | Q39466803 | ||
| Tear secretion induced by selective stimulation of corneal and conjunctival sensory nerve fibers. | Q42463905 | ||
| Diadenosine polyphosphates in tears of Sjogren syndrome patients | Q43059477 | ||
| The conjunctival epithelium in dry eye subtypes: effect of preserved and non-preserved topical treatments | Q43637103 | ||
| Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface | Q45158772 | ||
| Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study). | Q46134690 | ||
| Long-term incidence of dry eye in an older population | Q46447847 | ||
| Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye. | Q46460231 | ||
| The controlled-environment chamber: a new mouse model of dry eye. | Q46618772 | ||
| ZAP-70 and defects of T-cell receptor signaling | Q46649460 | ||
| Vaginal dryness: a comparison of prevalence and interventions in 11 countries | Q47578707 | ||
| Analysis of inflammatory cytokines in the tears of dry eye patients. | Q54467014 | ||
| Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. | Q54643325 | ||
| [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications] | Q57176801 | ||
| Nerves and sensations from the eye surface | Q59282362 | ||
| Sjögren’s syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB | Q59381645 | ||
| [A molecular marker for dry eye] | Q79938484 | ||
| Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007) | Q80347912 | ||
| Tear osmolarity in the diagnosis and management of dry eye disease | Q83395082 | ||
| Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis | Q83540725 | ||
| Surgical management of lacrimal punctal cauterization in chronic GVHD-related dry eye with recurrent punctal plug extrusion | Q83682081 | ||
| [Sex hormones and dry eye] | Q84957119 | ||
| P433 | issue | 1 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 19-30 | |
| P577 | publication date | 2013-12-14 | |
| P1433 | published in | Saudi journal of ophthalmology | Q26854011 |
| P1476 | title | Recent developments on dry eye disease treatment compounds | |
| P478 | volume | 28 |
| Q59104204 | A Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, and Future Challenges |
| Q54222666 | A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye. |
| Q42044298 | Assessment of Tear Film Quality among Smokers Using Tear Ferning Patterns |
| Q64084419 | Assessment of the tear film in normal eye subjects after consumption of a single dose of hot peppermint drink |
| Q28389937 | Clinical evaluation of a nutraceutical diet as an adjuvant to pharmacological treatment in dogs affected by Keratoconjunctivitis sicca |
| Q26747001 | Dry Eye Syndrome in Patients with Diabetes Mellitus: Prevalence, Etiology, and Clinical Characteristics |
| Q58702689 | Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment |
| Q26771221 | In pursuit of objective dry eye screening clinical techniques |
| Q39878699 | In vivo tissue distribution and efficacy studies for cyclosporin A loaded nano-decorated subconjunctival implants. |
| Q33838722 | Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome |
| Q36326806 | Preclinical mouse model to monitor live Muc5b-producing conjunctival goblet cell density under pharmacological treatments |
| Q88735143 | Subconjunctival dendrimer-drug therapy for the treatment of dry eye in a rabbit model of induced autoimmune dacryoadenitis |
| Q58804205 | Useful In Vitro Techniques to Evaluate the Mucoadhesive Properties of Hyaluronic Acid-Based Ocular Delivery Systems |
Search more.